OPKO Health (OPK) Submitted PMA Application with FDA for Point-of-Care PSA Test with Claros 1 Platform
Tweet Send to a Friend
OPKO Health, Inc. (NASDAQ: OPK) announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
